InsideArbitrage Event Driven Monitor – May 4, 2026

Note: You can click on any section title to jump straight to the related tool or page. Merger Arbitrage ESPR: The acquisition of Esperion Therapeutics, Inc. (ESPR) by ARCHIMED for a closing value of up to $1.1 billion. Esperion shareholders will receive $3.16 per share in cash, representing a premium of 58% from the stock’s